When multivariate analyses are adjusted for mutation in BCOR, ASXL1, and RUNX1—which are more commonly found in STAG2-mutated AML compared to other subsets-STAG2 mutations—they lose their independent prognostic impact. The gene discussed is BCOR; the disease is acute myeloid leukemia.